近岸蛋白
(688137)
| 流通市值：112.14亿 | | | 总市值：112.14亿 |
| 流通股本：6991.75万 | | | 总股本：6991.75万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 78,496,109.52 | 37,246,747.9 | 146,439,493.07 | 111,854,902.43 |
| 营业收入 | 78,496,109.52 | 37,246,747.9 | 146,439,493.07 | 111,854,902.43 |
| 二、营业总成本 | 96,100,027.51 | 43,448,993.89 | 185,997,982.61 | 131,176,781.29 |
| 营业成本 | 24,526,413.47 | 11,064,674.78 | 48,146,398.72 | 39,328,137.42 |
| 税金及附加 | 487,670.44 | 179,682.97 | 1,498,955.9 | 1,060,484.39 |
| 销售费用 | 28,943,487.83 | 13,106,384.31 | 56,854,063.77 | 40,258,262.1 |
| 管理费用 | 18,175,913.76 | 8,573,174.94 | 43,199,861.37 | 32,290,964.84 |
| 研发费用 | 34,085,172.37 | 15,925,524.66 | 64,062,418.94 | 40,248,363.71 |
| 财务费用 | -10,118,630.36 | -5,400,447.77 | -27,763,716.09 | -22,009,431.17 |
| 其中:利息费用 | 1,188,772.92 | 610,134.74 | 2,543,604.87 | 1,993,226.52 |
| 其中:利息收入 | 13,287,271.83 | 6,984,720.36 | 31,728,189.73 | 24,774,916.38 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 419,278.25 | - | - | - |
| 加:投资收益 | - | - | 267,479.91 | 267,479.91 |
| 资产处置收益 | 34,124 | - | 731,409.51 | 731,409.51 |
| 资产减值损失(新) | -12,074,278.89 | -4,614,810.65 | -33,022,880.96 | -21,976,820.24 |
| 信用减值损失(新) | 191,339.49 | -758,207.03 | 1,091,138.04 | 1,283,983.32 |
| 其他收益 | 304,586.5 | 133,609.33 | 636,426.56 | 881,071.31 |
| 四、营业利润 | -28,728,868.64 | -11,441,654.34 | -69,854,916.48 | -38,134,755.05 |
| 加:营业外收入 | 19,117.87 | 19,117.5 | 19,190.16 | 18,846.83 |
| 减:营业外支出 | 48,163.49 | 37,212.46 | 537,840.26 | 386,273.79 |
| 五、利润总额 | -28,757,914.26 | -11,459,749.3 | -70,373,566.58 | -38,502,182.01 |
| 减:所得税费用 | 446,594.56 | -855,381.55 | 7,409,824.98 | -9,642,913.51 |
| 六、净利润 | -29,204,508.82 | -10,604,367.75 | -77,783,391.56 | -28,859,268.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -29,204,508.82 | -10,604,367.75 | -77,783,391.56 | -28,859,268.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -29,204,508.82 | -10,604,367.75 | -77,783,391.56 | -28,859,268.5 |
| 扣除非经常损益后的净利润 | -29,775,703.75 | -10,603,078.52 | -77,120,244.53 | -32,639,345.14 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.42 | -0.15 | -1.11 | -0.41 |
| (二)稀释每股收益 | -0.42 | -0.15 | -1.11 | -0.41 |
| 八、其他综合收益 | 269,942.66 | 126,512.97 | 113,649.11 | 41,526.76 |
| 归属于母公司股东的其他综合收益 | 269,942.66 | 126,512.97 | 113,649.11 | 41,526.76 |
| 九、综合收益总额 | -28,934,566.16 | -10,477,854.78 | -77,669,742.45 | -28,817,741.74 |
| 归属于母公司股东的综合收益总额 | -28,934,566.16 | -10,477,854.78 | -77,669,742.45 | -28,817,741.74 |
| 公告日期 | 2026-08-28 | 2026-04-29 | 2026-04-29 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |